§ 13F · FUND PROFILE
ADAR1 Capital Management, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $1.1B (13F)Positions · 220Turnover · — · Q1Filed · May 18, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$200M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 18, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | 1.39M | $155M | 9.1% | −45% |
| 2 | PTGX | PROTAGONIST THERAPEUTICS INC | 994K | $105M | 6.2% | −53% |
| 3 | ROIV | ROIVANT SCIENCES LTD | 3.29M | $91M | 5.4% | −52% |
| 4 | IMVT | IMMUNOVANT INC | 2.68M | $67M | 3.9% | −46% |
| 5 | SPY | STATE STR SPDR S&P 500 ETF T | 76K | $49M | 2.9% | −31% |
| 6 | TERN | TERNS PHARMACEUTICALS INC | 915K | $48M | 2.8% | +3% |
| 7 | CYTK | CYTOKINETICS INC | 633K | $42M | 2.5% | −41% |
| 8 | CRNX | CRINETICS PHARMACEUTICALS IN | 1.14M | $41M | 2.4% | +84% |
| 9 | BOXX | EA SERIES TRUST | 337K | $39M | 2.3% | −50% |
| 10 | DNLI | DENALI THERAPEUTICS INC | 1.87M | $36M | 2.1% | +1695% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ADAR1 SIGNAL
AC read
ADAR1 Capital Management, LLC is a Other fund managing $1.1 billion in assets. The fund runs a broad portfolio of 220 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed